Dr. Bahl is Senior Vice President of the Clinical Alliances, responsible for leading Magellan’s efforts to strengthen clinical advocacy and scientific innovation in collaboration with the Magellan Cares Foundation. She serves on the Clinical Committee, which establishes management principles and considers major initiatives across Magellan’s business units. As a member of the Magellan Studio Advisory Board, Dr. Bahl focuses on how the integration of physical, behavioral and pharmacy services impacts the lives of the consumers Magellan serves and the communities in which they live. help you think about innovations from a clinical perspective.
She is an experienced healthcare executive with over 30 years of experience leading operations, market strategy, business development, network development and direct delivery of care. Dr. Bahl was an early participant in the American Biodyne-managed behavioral health industry. She led a private practice in her hometown of Miami, Florida, employing psychologists and social workers. She serves on the Scientific Advisory Board of Shatterproof, a non-profit organization that reduces stigma and raises awareness of addiction.
Prior to joining Magellan Health, he spent 29 years at Optum, expanding his responsibilities and being part of the Optum Behavioral Health Senior Leadership Team. During her tenure at Optum, she led the Consultant Advisory Board, co-led the Customer Advisory Board, sponsored her sponsors at large corporations and state government executives, and led the sales team. She was honored as a corporate leader at Moffly Media’s 2018 Annual Women in Business Conference in recognition of her lifetime contribution to sales at Optum. Dr. Bahl holds a Bachelor of Science degree in Psychology from the University of Florida and completed her Ph.D. She holds a PhD in Clinical Psychology from the University of Miami.
